Literature DB >> 18176393

[Necrotizing pneumonia due to Gemella morbillorum in an immunocompetent patient].

M Estivals1, S Mermond, C Barbe, L du Couëdic, L du Covedic, S Birolleau, H Levenes.   

Abstract

BACKGROUND: Gemella morbillorum is an anaerobic to aerotolerant Gram positive coccus. It is considered a member of the normal upper respiratory tract flora including the oropharynx and also the gastro-intestinal and female genital tract. However severe infections are reported like endocarditis, septic shock and septic arthritis, more often in immunocompromised hosts. It is an infrequently isolated organism and a rare cause of pulmonary or pleural infections. CASE REPORT: We report a case of necrotizing pneumonia due to Gemella morbillorum in a 45-years-old Melanesian, smoker patient. The presentation was subacute with a four month history of loss of appetite, progressive weight loss and cough without fever. Initial presentation seems to be a malignant disease. The positive diagnosis has been established on the results of BAL fluid and the protected specimen brush samples. It was an immunocompetent patient presenting dental inflammation but not oral infection. Further management included intravenous administration of amoxicillin during two weeks. We recommended oral antibiotic treatment for another six weeks. After two months the patient was reevaluated. The CT scan showed no evidence of persistent infection. The HR CT scan will reveal multiple kystic bronchiectasies not seen on the first CT scan.
CONCLUSION: Gm can be found endoscopic samples. Gemella morbillorum can be responsible of community-acquired pneumonia in immunocompetent host.

Entities:  

Mesh:

Year:  2007        PMID: 18176393     DOI: 10.1016/s0761-8425(07)74266-3

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  1 in total

1.  Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy.

Authors:  Matthias G Vossen; Klaus B Gattringer; Neda Khalifeh; Maria Koreny; Verena Spertini; Ammar Mallouhi; Markus Willeit; Beatrix Volc-Platzer; Friederike Asboth; Wolfgang Graninger; Florian Thalhammer; Heimo Lagler
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.